Synthesis of thyroid hormone analogues. Part 3. Iodonium salt approaches to SK&F L-94901
Authors:
- Deirdre M. B. HickeyDHDeirdre M. B. Hickey
- Paul D. LeesonPLPaul D. Leeson
- Riccardo NovelliRNRiccardo Novelli
- Virendra P. ShahVSVirendra P. Shah
- Brian E. BurpittBBBrian E. Burpitt
- Lynne P. CrawfordLCLynne P. Crawford
- Bryan J. DaviesBDBryan J. Davies
- Michael B. MitchellMMMichael B. Mitchell
- Kirit D. PancholiKPKirit D. Pancholi
- David TuddenhamDTDavid Tuddenham
- Norman J. LewisNLNorman J. Lewis
- Clare O'FArrellCOClare O'FArrell
- 1 January 1988
- journal article
- research article
- Published by Royal Society of Chemistry (RSC) in Journal of the Chemical Society, Perkin Transactions 1
- No. 12,p. 3103-3111
Abstract
The key step in the synthesis of L-3,5-dibromo-3′-[6-oxo-1,6-dihydropyridazin-3-yl)methyl]-thyronine, SK&F L-94901 (1), a novel, selective, and potent thyromimetic, is the formation of the hindered diaryl ether moiety. This paper describes an investigation into the formation of the required diaryl ether by copper-catalysed reaction both of symmetrical iodonium salts (2a) and (10) and mixed iodonium salts (2b–e) with protected dibromotyrosine (5). The importance of the counter-ion of the iodonium salt is discussed. This work is extended to a large-scale synthesis of SK&F L-94901 (1).Keywords
This publication has 3 references indexed in Scilit:
- Highly stabilized copper(III) complexesJournal of the American Chemical Society, 1987
- VARIOUS EFFECTS OF THYROXINE ANALOGUES ON THE HEART AND SERUM CHOLESTEROL IN THE RATJournal of Endocrinology, 1960
- THE EFFECT OF CERTAIN THYROXINE ANALOGUES ON THE SERUM LIPIDS IN HUMAN SUBJECTSJournal of Endocrinology, 1960